Xanax Recalled Nationwide Due to Dissolution Issues

The FDA has announced a recall of a single lot of the anti-anxiety medication due to failed dissolution specifications.

Apr. 15, 2026 at 6:22pm

Got story updates? Submit your updates here. ›

An extreme close-up X-ray photograph revealing the glowing, ghostly molecular structure of Xanax pills against a dark background, conceptually illustrating the quality control issues that led to the nationwide recall.An X-ray view of the recalled Xanax medication exposes the internal molecular structure, highlighting the dissolution issues that prompted the nationwide recall.Morgantown Today

The Food and Drug Administration has announced a nationwide recall of a single lot of the anti-anxiety medication Xanax. The recall affects lot 8177156, which expires on 02/28/2027, due to the pills failing to meet dissolution specifications. The recalled Xanax came in 3 mg pills with 60 tablets per bottle, distributed by Viatris Specialty of Morgantown, West Virginia. The pills were produced in Ireland and distributed in the U.S. from August 2024 to May 2025.

Why it matters

Dissolution issues with medications can impact the drug's effectiveness and safety, so the FDA has classified this as a Class II recall, meaning there is a remote probability of serious adverse health consequences. Patients taking this medication should stop use and contact their healthcare provider.

The details

The recalled Xanax has the NDC number 58151-506-91 and was initially recalled on March 17, 2026. The recall was then classified as a Class II on April 8, 2026. A Class II recall indicates that use of the product may cause temporary or medically reversible adverse health consequences, but the probability of serious harm is remote.

  • The recalled Xanax was distributed in the U.S. from August 27, 2024 to May 29, 2025.
  • The recall was initially announced on March 17, 2026.
  • The recall was classified as a Class II on April 8, 2026.

The players

Food and Drug Administration

The federal agency responsible for regulating and supervising the safety of food, drugs, and other products.

Viatris Specialty

The pharmaceutical company that distributed the recalled Xanax, based in Morgantown, West Virginia.

Got photos? Submit your photos here. ›

What’s next

Patients who have the recalled Xanax should stop using the medication and contact their healthcare provider.

The takeaway

This recall highlights the importance of quality control in the pharmaceutical industry, as dissolution issues can impact the effectiveness and safety of medications. Patients should always be vigilant about medication recalls and consult their doctors if they have any concerns.